Brain+ A/S
CSE:BRAINP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
Japan Logistic Systems Corp
TSE:9060
|
JP |
|
S
|
Stereotaxis Inc
F:RJR1
|
US |
Brain+ A/S
Other
Brain+ A/S
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Brain+ A/S
CSE:BRAINP
|
Other
-kr1.9m
|
CAGR 3-Years
15%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
N
|
NNIT A/S
CSE:NNIT
|
Other
kr0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
M
|
Monsenso A/S
CSE:MONSO
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Brain+ A/S
Glance View
Brain+ A/S is engaged in the developing of medical software to detect and treat the cognitive symptoms of dementia and the most common cause of dementia, namely Alzheimer's disease. The firm focuses on the development of digital treatment for dementia and Alzheimer’s disease by digital therapeutics. The Company’s main activities include the development of Cognitive Stimulation Therapy for the treatment of dementia, Computerized Cognitive Training for the treatment of earlier stages of Alzheimer’s and Starry Night memory test for early detection and monitoring of Alzheimer’s. The company offers a product called Digital CST assistant giving access to Cognitive Stimulation Therapy sessions, available in Danish.
See Also
What is Brain+ A/S's Other?
Other
-1.9m
DKK
Based on the financial report for Dec 31, 2024, Brain+ A/S's Other amounts to -1.9m DKK.
What is Brain+ A/S's Other growth rate?
Other CAGR 3Y
15%
Over the last year, the Other growth was 44%. The average annual Other growth rates for Brain+ A/S have been 15% over the past three years .
